Autologous NY-ESO-1-Melanoma-Specific CD8 T-lymphocytes
Cancer Terms ->
Drugs and Chemicals ->
Pharmacologic Substance ->
Biological Agent ->
Autologous Lymphocytes -> Autologous NY-ESO-1-Melanoma-Specific CD8 T-lymphocytes
Autologous NY-ESO-1-Melanoma-Specific CD8 T-lymphocytes Definition
A preparation of autologous CD8+ (cytotoxic) T-lymphocytes sensitized to cancer-testis antigen NY-ESO-1 antigen with potential immunostimulating and antineoplastic activities. Autologous CD8+ T-lymphocytes, isolated from a melanoma patient, are exposed to an NY-ESO-1 peptide ex vivo, expanded, and reintroduced into the patient; these tumor-reactive T-cells may stimulate a host immune response against tumor cells expressing the NY-ESO-1 antigen, resulting in tumor cell lysis. NY-ESO-1, an antigen found in normal testis, may be upregulated in various cancers, including bladder, breast, hepatocellular, melanoma, and prostate cancers.
Autologous NY-ESO-1-Melanoma-Specific CD8 T-lymphocytes Synonyms
Autologous NY-ESO-1-Melanoma-Specific CD8+ T-lymphocytes
Terms in Autologous NY-ESO-1-Melanoma-Specific CD8 T-lymphocytes category
Copyright © Cancer Terms 2014 All rights reserved. | Terms of Use | Low Carb Foods
No reproduction or republication permitted.